Company profile for Mithra Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Mithra is dedicated to providing innovation and choice in women’s health, with a particular focus on fertility, contraception and menopause. Mithra’s goal is to develop new and improved products that meet women’s needs for better safety and convenience.
Its two lead development candidates – a fifth generation oral contraceptive, Estelle®, and a next generation hormone therapy, Donesta® – are built on Mithra’...
Mithra is dedicated to providing innovation and choice in women’s health, with a particular focus on fertility, contraception and menopause. Mithra’s goal is to develop new and improved products that meet women’s needs for better safety and convenience.
Its two lead development candidates – a fifth generation oral contraceptive, Estelle®, and a next generation hormone therapy, Donesta® – are built on Mithra’s unique natural estrogen platform, E4 (Estetrol). Mithra also develops, manufactures and markets complex therapeutics and offers partners a complete spectrum of research, development and specialist manufacturing at its Mithra CDMO.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Belgium
Address
Address
Rue Saint-Georges 5 4000 Liège
Telephone
Telephone
+32 (0)4 349 28 22
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/05/28/2889117/0/en/Mithra-postpones-its-annual-general-meeting.html

GLOBENEWSWIRE
28 May 2024

https://www.globenewswire.com/news-release/2024/05/03/2875234/0/en/Mithra-enters-into-exclusive-negotiations-with-Gedeon-Richter-and-secures-continued-funding-in-the-context-of-its-monetization-process.html

GLOBENEWSWIRE
03 May 2024

https://www.globenewswire.com/news-release/2024/04/29/2870891/0/en/Mithra-updates-on-offers-received-in-the-context-of-its-monetization-process-and-on-its-Annual-Report-2023.html

GLOBENEWSWIRE
29 Apr 2024

https://www.globenewswire.com/news-release/2024/04/22/2866527/0/en/Mithra-secures-court-protection-measures-to-advance-monetization-process.html

GLOBENEWSWIRE
22 Apr 2024

https://www.globenewswire.com/news-release/2024/03/08/2842886/0/en/Mithra-reports-full-year-2023-financial-results.html

GLOBENEWSWIRE
08 Mar 2024

https://www.globenewswire.com//news-release/2024/03/05/2840081/0/en/Mithra-announces-changes-to-its-executive-management.html

GLOBENEWSWIRE
05 Mar 2024

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty